Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Most Shorted Stocks
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Investors
Private Companies
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Careers
Contact Us
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
MCP for Agents
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Most Shorted Stocks
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Center
Investors
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
ABBV
Stock Latest News
Analysts
AbbVie Stock Forecast: Trending StrongBuy Signals More Upside
53m ago
ABBV
Premium
The Fly
AbbVie announces Phase 3 Cervino study met dual primary endpoints of ORR, PFS
1d ago
ABBV
Premium
Company Announcements
AbbVie Closes Apogee Acquisition to Expand Immunology Portfolio
1d ago
8K
ABBV
Premium
The Fly
AbbVie completes acquisition of Apogee for $135.11 per share in cash
1d ago
ABBV
APGE
Premium
The Fly
AbbVie’s Allergan expands SkinMedica’s portfolio with Barrier Calming Cream
3d ago
ABBV
Premium
Company Announcements
AbbVie Targets Rare Blood Disorder With New Phase 3 Etentamig Trial Plan
7d ago
ABBV
Premium
Company Announcements
AbbVie Expands Its IBD Pipeline With New Phase 2 Basket Trial in Crohn’s and Ulcerative Colitis
7d ago
ABBV
Premium
The Fly
AbbVie submits Skyrizi application to the EMA
8d ago
ABBV
Premium
The Fly
Trump Trade: Canada rolls out 50% tariffs on U.S. metals
9d ago
AA
MT
Premium
The Fly
HHS plans to add FDA deputy roles for technology, drugs, CNBC says
10d ago
ABT
BMY
Premium
Weekend Updates
Johnson & Johnson, AbbVie, Chevron, Energy Transfer, Home Depot Shaken
13d ago
ET
HD
Premium
Company Announcements
AbbVie Expands Aesthetics Pipeline With New Phase 2 Forehead Lines Study
14d ago
ABBV
Premium
Company Announcements
AbbVie Targets Pediatric Alopecia With New Phase 3 Trial: What Investors Should Watch
14d ago
ABBV
Premium
Company Announcements
AbbVie’s Emraclidine Schizophrenia Study Ends Early: What Investors Need to Know Now
14d ago
ABBV
Premium
Company Announcements
AbbVie Targets Next-Gen BOTOX Combo With New Glabellar Lines Study
15d ago
ABBV
Premium
The Fly
AbbVie price target raised to $303 from $298 at Piper Sandler
15d ago
ABBV
Premium
Company Announcements
AbbVie Raises $9 Billion Debt to Fund Acquisition
17d ago
8K
ABBV
Premium
Market News
3 Dividend ETFs Crushing the S&P 500 in 2026
18d ago
VZ
CVX
Premium
The Fly
AbbVie price target raised to $300 from $295 at Wells Fargo
18d ago
ABBV
Premium
The Fly
AbbVie upgraded to Outperform from Peer Perform at Wolfe Research
18d ago
ABBV
Premium
The Fly
Apogee Therapeutics price target raised to $135 from $81 at Truist
18d ago
ABBV
APGE
Premium
Company Announcements
AbbVie Steps Deeper Into Alzheimer’s: What the ABBV-1758 Trial Means for Investors
21d ago
ABBV
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >
You need to enable JavaScript to run this app.